share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  11/12 15:19

Moomoo AI 已提取核心訊息

On November 12, 2024, Adial Pharmaceuticals, Inc. conducted its 2024 Annual Meeting of Stockholders, where several key proposals were voted upon. The stockholders approved an amendment to the company's 2017 Equity Incentive Plan, increasing the number of shares authorized for grant from 500,000 to 2,000,000. Additionally, two Class III directors were re-elected to serve a three-year term, and Marcum, LLP was ratified as the company's independent registered public accounting firm for the year ending December 31, 2024. The compensation of named executive officers was approved on an advisory basis, and a three-year frequency for future advisory votes on executive compensation was established. The Board of Directors has decided to adhere to this frequency for holding advisory votes on executive compensation.
On November 12, 2024, Adial Pharmaceuticals, Inc. conducted its 2024 Annual Meeting of Stockholders, where several key proposals were voted upon. The stockholders approved an amendment to the company's 2017 Equity Incentive Plan, increasing the number of shares authorized for grant from 500,000 to 2,000,000. Additionally, two Class III directors were re-elected to serve a three-year term, and Marcum, LLP was ratified as the company's independent registered public accounting firm for the year ending December 31, 2024. The compensation of named executive officers was approved on an advisory basis, and a three-year frequency for future advisory votes on executive compensation was established. The Board of Directors has decided to adhere to this frequency for holding advisory votes on executive compensation.
2024年11月12日,Adial Pharmaceuticals, Inc.進行了其2024年股東大會,股東們就幾項重要提案進行了投票。股東批准了對公司2017年股權激勵計劃的修正案,將授權用於授予的股票數量從50萬股增加到200萬股。此外,兩名第三類董事連任三年任期,Marcum,LLP被確認爲公司截至2024年12月31日的獨立註冊會計師。命名執行官的薪酬獲得了諮詢意見的批准,並確定了未來對執行官薪酬進行諮詢表決的三年週期。董事會決定遵守這一頻率,進行有關執行官薪酬的諮詢表決。
2024年11月12日,Adial Pharmaceuticals, Inc.進行了其2024年股東大會,股東們就幾項重要提案進行了投票。股東批准了對公司2017年股權激勵計劃的修正案,將授權用於授予的股票數量從50萬股增加到200萬股。此外,兩名第三類董事連任三年任期,Marcum,LLP被確認爲公司截至2024年12月31日的獨立註冊會計師。命名執行官的薪酬獲得了諮詢意見的批准,並確定了未來對執行官薪酬進行諮詢表決的三年週期。董事會決定遵守這一頻率,進行有關執行官薪酬的諮詢表決。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息